The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association and lobbying organisation, founded in 1978 and representing the pharmaceutical industry operating in Europe. Through its membership of 36 national associations and 39 leading pharmaceutical companies, the EFPIA represents 1,900 European companies.
Addiction is a monthly peer-reviewed scientific journal established in 1903 by the Society for the Study of Addiction to Alcohol and other Drugs as the British Journal of Inebriety. It was renamed British Journal of Addiction to Alcohol & Other Drugs in 1947, then renamed to British Journal of Addiction in 1980, before finally obtaining its current name in 1993. It covers research relating to the abuse of alcohol, illicit drugs, and tobacco, as well as behavioural addictions. The editor-in-chief is John Marsden.
Arena Pharmaceuticals, Inc. is an American biopharmaceutical company founded in 1997 and headquartered in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. The company's most advanced investigational clinical programs are ralinepag in testing for pulmonary arterial hypertension (PAH), etrasimod in evaluation for inflammatory indications and APD371 for the treatment of pain associated with Crohn's disease. In 2016, the company downsized and shifted its focus to developing new drugs currently being tested in clinical trials. In December 2021, Pfizer announced that it had agreed to acquire Arena for $6.7 billion in cash. In March 2022, it was announced the acquisition by Pfizer had been concluded.
Molecular Pharmaceutics is a peer-reviewed scientific journal covering research on the molecular mechanistic understanding of drug delivery and drug delivery systems, including physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science.
Drugs is a peer-reviewed medical journal published by Adis International that covers topics in drugs and therapeutics. Besides research articles, the journal also publishes "Adis Drug Evaluations and AdisInsight Reports", evidence-based, single-agent reviews.
The Indian Journal of Pharmaceutical Sciences is a bimonthly peer-reviewed open-access medical journal covering pharmaceutics, biopharmaceutics, pharmaceutical chemistry, pharmacognosy, pharmacology, pharmaceutical analysis, pharmacy practice, and clinical and hospital pharmacy. Since March 2016, it is published on behalf of the Indian Pharmaceutical Association by OMICS International, which is included in Jeffrey Beall's list of "potential, possible, or probable predatory publishers". OMICS International replaced Medknow Publications, which had published the journal for 10 years. It was established in 1939 as the Indian Journal of Pharmacy, with M.L. Schroff as founding editor-in-chief.
The Journal of Controlled Release is a biweekly peer-reviewed medical journal and the official journal of the Controlled Release Society. The journal covers research on the controlled release and delivery of drugs and other biologically active agents. Announcements and reports of future meetings pertaining to the activities of the Controlled Release Society are also included.
The Journal of the National Cancer Institute (JNCI) is a peer-reviewed medical journal covering research in oncology that was established in August 1940. It is published monthly by Oxford University Press and is edited by Patricia A. Ganz. It was merged with Cancer Treatment Reports in January 1988. JNCI used to be the official journal of the U.S. National Cancer Institute (NCI); however, in 1996, the NCI and JNCI agreed to grow apart. Over the next five years, JNCI became independent of the NCI.
Therapeutic Innovation & Regulatory Science is a bimonthly peer-reviewed medical journal that covers research and developments concerning pharmaceuticals and the development and use of medical products. It is published by Springer Nature on behalf of the Drug Information Association. The journal was established in 1967 as the Drug Information Bulletin and renamed to Drug Information Journal in 1971, before obtaining its current title in 2013. The editor-in-chief is Gregory W. Daniel.
The Journal of Clinical Pharmacology is a peer-reviewed medical journal that covers the field of pharmacology. The editor-in-chief is Joseph S. Bertino, Jr.. It was established in 1961 and is currently published by John Wiley & Sons in association with the American College of Clinical Pharmacology.
The European Journal of Pharmaceutics and Biopharmaceutics is a peer-reviewed medical journal and the official journal of the International Association for Pharmaceutical Technology. It publishes research on pharmaceutical technology, pharmaceutical biotechnology, and biopharmaceutics.
CNS Drugs is a monthly peer-reviewed medical journal published by Adis International that covers drug treatment of psychiatric and neurological disorders.
The Journal of the American Pharmacists Association is a bimonthly peer-reviewed medical journal covering pharmacy-related topics. It was established in 1912, published as Journal of the American Pharmaceutical Association with slightly varying title until 1977, as American Pharmacist, then again as the Journal of the American Pharmaceutical Association ; it obtained its current title in 2003, and is the official journal of the American Pharmacists Association. The current editor-in-chief is Pamela Heaton, PhD, BSPharm, MS.
Leslie 'Les' Zachary Benet is an influential pharmaceutical scientist heading the UCSF's Benet Lab at the Department of Bioengineering and Therapeutic Sciences and recipient of the Remington Medal for distinguished service to American pharmacy.
María José Alonso Fernandez is a full professor of biopharmaceutics and pharmaceutical technology at the University of Santiago de Compostela. The laboratory she leads is specialized in pharmaceutical nanotechnology and nanomedicine, and her research is oriented to the development of nanostructures for targeted delivery of drugs and vaccines. Her discoveries have led to significant clinical advances in the development of potential new treatments for cancer, ocular diseases, skin diseases, diabetes, obesity and other autoimmune pathologies, as well as new vaccines.
The Systematic Reviews in Pharmacy is a monthly peer-reviewed open-access medical journal covering pharmaceutics, biopharmaceutics, pharmaceutical chemistry, pharmacognosy, pharmacology, pharmaceutical analysis, pharmacy practice, clinical and Biomedical sciences.
The Journal of Drug and Alcohol Research is a monthly peer-reviewed open-access medical journal covering addiction, addiction psychology, alcoholism, biopharmaceutics, pharmaceutical chemistry, pharmacognosy, pharmacology, a,d clinical and biomedical sciences. It is published by Ashdin Publishing, which was listed on Beall's list of predatory publishers before it was taken down in 2017.
The Indian Journal of Pharmaceutical Education and Research is a quarterly peer-reviewed open-access medical journal covering pharmaceutics, biopharmaceutics, pharmaceutical analysis, pharmacy practice, clinical pharmacy, and pharmacy education. It is published by the Association of Pharmaceutical Teachers of India and the editor-in-chief is M. Ahmed.
Journal of Pharmaceutical and Biomedical Analysis is a peer-reviewed medical journal that covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences. The journal is published by Elsevier.
